Home > Boards > US Listed > Biotechs > ONCTERNAL THERAPEUTICS, INC (ONCT)

Here we go shareholders deserve reward after holding

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Lanceo Member Profile
 
Followed By 6
Posts 404
Boards Moderated 0
Alias Born 12/19/17
160x600 placeholder
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 12/22/2020 6:01:49 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 12/18/2020 4:06:08 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 12/10/2020 5:03:17 PM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 12/10/2020 6:12:54 AM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 12/10/2020 6:05:09 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 12/10/2020 6:02:43 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/7/2020 8:16:01 AM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 11/24/2020 4:39:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/19/2020 5:07:40 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/19/2020 6:04:46 AM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 11/18/2020 6:06:18 AM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 11/17/2020 5:28:36 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/17/2020 5:08:04 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/4/2020 5:12:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/4/2020 5:01:27 PM
Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments PR Newswire (Canada) - 9/22/2020 7:00:00 AM
Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments PR Newswire (US) - 9/22/2020 7:00:00 AM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 9/9/2020 5:24:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/2/2020 4:53:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/31/2020 4:34:59 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/28/2020 5:25:04 PM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 8/28/2020 6:16:31 AM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 8/27/2020 5:44:32 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/27/2020 5:44:31 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/27/2020 4:53:39 PM
Lanceo   Friday, 05/31/19 12:01:31 PM
Re: None
Post # of 1413 
Here we go shareholders deserve reward after holding for good action from GTXI.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences